The Allstate Corporation (NYSE:ALL) Shares Sold by Kintegral Advisory LLC

Kintegral Advisory LLC reduced its holdings in The Allstate Corporation (NYSE:ALL - Free Report) by 32.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,978 shares of the insurance provider's stock after selling 1,950 shares during the period. Kintegral Advisory LLC's holdings in Allstate were worth $828,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALL. Catalyst Capital Advisors LLC grew its position in Allstate by 45.2% in the first quarter. Catalyst Capital Advisors LLC now owns 527 shares of the insurance provider's stock worth $109,000 after acquiring an additional 164 shares during the period. IFM Investors Pty Ltd grew its holdings in shares of Allstate by 9.4% during the 1st quarter. IFM Investors Pty Ltd now owns 53,111 shares of the insurance provider's stock worth $10,073,000 after purchasing an additional 4,577 shares during the period. GF Fund Management CO. LTD. acquired a new stake in shares of Allstate during the 1st quarter worth about $97,000. OneDigital Investment Advisors LLC increased its position in shares of Allstate by 22.1% during the 1st quarter. OneDigital Investment Advisors LLC now owns 5,497 shares of the insurance provider's stock worth $1,138,000 after purchasing an additional 996 shares during the last quarter. Finally, Calamos Advisors LLC lifted its holdings in shares of Allstate by 1.1% in the 1st quarter. Calamos Advisors LLC now owns 99,254 shares of the insurance provider's stock worth $20,553,000 after acquiring an additional 1,104 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Stock Performance

ALL stock traded up $2.03 on Friday, hitting $196.72. The company's stock had a trading volume of 963,005 shares, compared to its average volume of 1,633,683. The stock has a market cap of $52.09 billion, a price-to-earnings ratio of 13.44, a price-to-earnings-growth ratio of 1.03 and a beta of 0.33. The Allstate Corporation has a 1 year low of $157.50 and a 1 year high of $213.18. The firm has a 50 day moving average of $201.37 and a two-hundred day moving average of $196.60. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.40.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing analysts' consensus estimates of $3.98 by ($0.45). The firm had revenue of $14.30 billion during the quarter, compared to analysts' expectations of $16.41 billion. Allstate had a net margin of 6.19% and a return on equity of 24.62%. The business's quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $5.13 earnings per share. Equities analysts predict that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Shareholders of record on Monday, June 9th were given a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 2.03%. The ex-dividend date of this dividend was Monday, June 9th. Allstate's payout ratio is 27.32%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on ALL shares. BMO Capital Markets reiterated an "outperform" rating on shares of Allstate in a report on Friday, May 16th. Raymond James Financial reiterated a "strong-buy" rating and issued a $250.00 price objective (up previously from $240.00) on shares of Allstate in a research note on Monday, May 5th. Evercore ISI lifted their price objective on shares of Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. JPMorgan Chase & Co. increased their target price on Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Finally, William Blair began coverage on Allstate in a research note on Friday, June 6th. They issued a "sector outperform" rating on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Allstate has an average rating of "Moderate Buy" and an average target price of $225.20.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.